Fox Chase Cancer Center News

The beginning of the New Year is a perfect time to reflect on your health and to learn ways you can reduce your risk for cancer. 

With this grant, the Sykes lab will seek to uncover molecular targets that can serve as a basis for developing novel acute myeloid leukemia (AML) therapies.

The American Cancer Society’s newly formed Pennsylvania/New Jersey Pay-If Research Council has funded Jaye Gardiner, PhD, to  continue her efforts to understand the signaling from cell-cell interactions in the pancreatic tumor microenvironment.

PHILADELPHIA (December 11, 2018) — Jonathan Chernoff, MD, PhD, chief scientific officer and Stanley P. Reimann Chair in Oncology Research at Fox Chase Cancer Center, has received a grant from the Melanoma Research Foundation to support his research on RAC1 mutant melanoma. 

Dr. Denise Connolly has led the way in changing how ovarian cancer is understood. Her lab pioneered the first transgenic mouse model that develops spontaneous ovarian carcinomas, making it easier for scientists everywhere to study ovarian cancers. 

PHILADELPHIA (November 28, 2018) – Warren D. Kruger, PhD,  has received a grant from the National Institutes of Health to study whether proteasome inhibitors (Pls) and proteostasis modulators are effective in restoring function to treating cystathionine beta synthase (CBS) deficiency, also known as classical homocystinuria.

PHILADELPHIA (November 26, 2018) – Y. Lynn Wang, MD, PhD, FCAP, is a board-certified molecular pathologist who specializes in the development and interpretation of molecular and genomic clinical assays including next-gen sequencing assays. As part of her transition, the Wang Lab was relocated to Fox Chase from the University of Chicago.

Looking back on the remarkable career of medical oncologist Paul F. Engstrom. who retires after nearly 50 years of service at Fox Chase Cancer Center